Group sequential crossover trial designs with strong control of the familywise error rate (Q4689943): Difference between revisions

From MaRDI portal
Changed an Item
ReferenceBot (talk | contribs)
Changed an Item
 
(8 intermediate revisions by 5 users not shown)
Property / author
 
Property / author: James M. S. Wason / rank
Normal rank
 
Property / author
 
Property / author: James M. S. Wason / rank
 
Normal rank
Property / describes a project that uses
 
Property / describes a project that uses: MEMSS / rank
 
Normal rank
Property / describes a project that uses
 
Property / describes a project that uses: S-PLUS / rank
 
Normal rank
Property / describes a project that uses
 
Property / describes a project that uses: Matlab / rank
 
Normal rank
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W2963880075 / rank
 
Normal rank
Property / arXiv ID
 
Property / arXiv ID: 1710.03492 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q3067798 / rank
 
Normal rank
Property / cites work
 
Property / cites work: A group sequential approach to crossover trials for average bioequivalence / rank
 
Normal rank
Property / cites work
 
Property / cites work: On Deriving the Inverse of a Sum of Matrices / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4264744 / rank
 
Normal rank
Property / cites work
 
Property / cites work: A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection / rank
 
Normal rank
Property / cites work
 
Property / cites work: Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis / rank
 
Normal rank
Property / cites work
 
Property / cites work: Ethical considerations concerning treatment allocation in drug development trials / rank
 
Normal rank

Latest revision as of 23:59, 16 July 2024

scientific article; zbMATH DE number 6959436
Language Label Description Also known as
English
Group sequential crossover trial designs with strong control of the familywise error rate
scientific article; zbMATH DE number 6959436

    Statements

    Group sequential crossover trial designs with strong control of the familywise error rate (English)
    0 references
    0 references
    0 references
    0 references
    22 October 2018
    0 references
    clinical trial
    0 references
    crossover
    0 references
    familywise error rate
    0 references
    group sequential
    0 references
    linear mixed model
    0 references
    0 references
    0 references
    0 references
    0 references

    Identifiers

    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references